The potential public health consequences of COVID-19 on malaria in Africa

Nat Med. 2020 Sep;26(9):1411-1416. doi: 10.1038/s41591-020-1025-y. Epub 2020 Aug 7.

Abstract

The burden of malaria is heavily concentrated in sub-Saharan Africa (SSA) where cases and deaths associated with COVID-19 are rising1. In response, countries are implementing societal measures aimed at curtailing transmission of SARS-CoV-22,3. Despite these measures, the COVID-19 epidemic could still result in millions of deaths as local health facilities become overwhelmed4. Advances in malaria control this century have been largely due to distribution of long-lasting insecticidal nets (LLINs)5, with many SSA countries having planned campaigns for 2020. In the present study, we use COVID-19 and malaria transmission models to estimate the impact of disruption of malaria prevention activities and other core health services under four different COVID-19 epidemic scenarios. If activities are halted, the malaria burden in 2020 could be more than double that of 2019. In Nigeria alone, reducing case management for 6 months and delaying LLIN campaigns could result in 81,000 (44,000-119,000) additional deaths. Mitigating these negative impacts is achievable, and LLIN distributions in particular should be prioritized alongside access to antimalarial treatments to prevent substantial malaria epidemics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / therapeutic use*
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / parasitology
  • Coronavirus Infections / virology
  • Humans
  • Insecticides / therapeutic use
  • Malaria / complications
  • Malaria / epidemiology*
  • Malaria / parasitology
  • Malaria / virology
  • Mosquito Control
  • Pandemics*
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / parasitology
  • Pneumonia, Viral / virology
  • Public Health
  • SARS-CoV-2

Substances

  • Antimalarials
  • Insecticides